Latest Breaking News On - Sun yat sen university cancer center - Page 1 : comparemela.com

Olverembatinib Demonstrates Early Activity, Tolerability in SDH-deficient GIST

Olverembatinib showed antitumor activity in patients with TKI-resistant, SDH-deficient GISTs and paraganglioma.

China
Guangzhou
Guangdong
Haibo-qiu
Ascentage-pharma
Sun-yat-sen-university-cancer-center

Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy

Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy
thailand-business-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thailand-business-news.com Daily Mail and Mail on Sunday newspapers.

China
France
Li-zhang
Zhejiang
Italy
United-states
Japan
Germany
Thailand
United-kingdom
Canada
Chicago

Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy | Taiwan News

Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy | Taiwan News
taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.

China
Chicago
Illinois
United-states
United-kingdom
Japan
Canada
Italy
Germany
Li-zhang
Zhejiang
France

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
jamanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamanetwork.com Daily Mail and Mail on Sunday newspapers.

China
Beijing
Yan-wang
Shaanxi
Fujian
Ying-cheng
Hubei
Lanzhou
Gansu
Jilin
Shanxi
Yinchuan

Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy

Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Canada
United-kingdom
Miami
Florida
United-states
Spain
California
China
Germany
Li-zhang
Zhejiang
Cleveland-clinic